These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 27018049)
1. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. Kitt H; Lenney W; Gilchrist FJ BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049 [TBL] [Abstract][Full Text] [Related]
2. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients. Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656 [TBL] [Abstract][Full Text] [Related]
3. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848 [TBL] [Abstract][Full Text] [Related]
4. Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem. Narayanaswamy VP; Giatpaiboon S; Baker SM; Wiesmann WP; LiPuma JJ; Townsend SM PLoS One; 2017; 12(6):e0179776. PubMed ID: 28662114 [TBL] [Abstract][Full Text] [Related]
5. Novel antibiotic combinations proposed for treatment of El-Halfawy OM; Naguib MM; Valvano MA Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [TBL] [Abstract][Full Text] [Related]
6. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526 [TBL] [Abstract][Full Text] [Related]
7. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Horsley A; Webb K; Bright-Thomas R; Govan J; Jones A Front Cell Infect Microbiol; 2011; 1():18. PubMed ID: 22919584 [TBL] [Abstract][Full Text] [Related]
8. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI? Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062 [No Abstract] [Full Text] [Related]
9. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970 [No Abstract] [Full Text] [Related]
10. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children. Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163 [TBL] [Abstract][Full Text] [Related]
11. Combination aerosol therapy to treat Burkholderia cepacia complex. Middleton PG; Kidd TJ; Williams B Eur Respir J; 2005 Aug; 26(2):305-8. PubMed ID: 16055880 [TBL] [Abstract][Full Text] [Related]
12. Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection. Waters V; Yau Y; Beaudoin T; Wettlaufer J; Tom SK; McDonald N; Rizvi L; Klingel M; Ratjen F; Tullis E J Cyst Fibros; 2017 Jul; 16(4):492-495. PubMed ID: 28262569 [TBL] [Abstract][Full Text] [Related]
13. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible? Etherington C; Peckham DG; Conway SP; Denton M J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878 [No Abstract] [Full Text] [Related]